These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 9337946)
1. Cost-effectiveness of clozapine. A UK clinic-based study. Aitchison KJ; Kerwin RW Br J Psychiatry; 1997 Aug; 171():125-30. PubMed ID: 9337946 [TBL] [Abstract][Full Text] [Related]
2. The pharmacoeconomics of clozapine: a review. Meltzer HY; Cola PA J Clin Psychiatry; 1994 Sep; 55 Suppl B():161-5. PubMed ID: 7961564 [TBL] [Abstract][Full Text] [Related]
3. [Medico-economic evaluation of treatment with clozapine versus treatment with previous neuroleptics]. Geronimi-Ferret D; Lesay M; Barges-Bertocchio MH; Cornet-Bonnefont M; Robert H Encephale; 1997 Sep; 23 Spec No 4():24-31. PubMed ID: 9417402 [TBL] [Abstract][Full Text] [Related]
4. New vs. old antipsychotics: the Texas experience. Reid WH J Clin Psychiatry; 1999; 60 Suppl 1():23-5; discussion 28-30. PubMed ID: 10037167 [TBL] [Abstract][Full Text] [Related]
5. [Medico-economic study of Léponex (clozapine) in the Bordeaux Charles Perrens Hospital Center]. Bret P; Jolivel C; Bret MC; Veylit S; Martin C; Garcia P Encephale; 1998; 24(4):365-77. PubMed ID: 9809242 [TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of clozapine in patients with high and low levels of hospital use. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia. Rosenheck R; Cramer J; Allan E; Erdos J; Frisman LK; Xu W; Thomas J; Henderson W; Charney D Arch Gen Psychiatry; 1999 Jun; 56(6):565-72. PubMed ID: 10359474 [TBL] [Abstract][Full Text] [Related]
7. The cost-effectiveness of clozapine: a controlled, population-based, mirror-image study. Hayhurst KP; Brown P; Lewis SW J Psychopharmacol; 2002 Jun; 16(2):169-75. PubMed ID: 12095076 [TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of clozapine therapy for severe psychosis. Ghaemi SN; Ziegler DM; Peachey TJ; Goodwin FK Psychiatr Serv; 1998 Jun; 49(6):829-31. PubMed ID: 9634167 [TBL] [Abstract][Full Text] [Related]
9. [The impact of antipsychotic medication on the incidence and the costs of inpatient treatment in people with schizophrenia: results from a prospective observational study]. Kilian R; Angermeyer MC Psychiatr Prax; 2004 Apr; 31(3):138-46. PubMed ID: 15042477 [TBL] [Abstract][Full Text] [Related]
10. Modelling the impact of clozapine on suicide in patients with treatment-resistant schizophrenia in the UK. Duggan A; Warner J; Knapp M; Kerwin R Br J Psychiatry; 2003 Jun; 182():505-8. PubMed ID: 12777341 [TBL] [Abstract][Full Text] [Related]
12. Cost effectiveness of clozapine in neuroleptic-resistant schizophrenia. Meltzer HY; Cola P; Way L; Thompson PA; Bastani B; Davies MA; Snitz B Am J Psychiatry; 1993 Nov; 150(11):1630-8. PubMed ID: 8105705 [TBL] [Abstract][Full Text] [Related]
13. A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia. Rosenheck R; Cramer J; Xu W; Thomas J; Henderson W; Frisman L; Fye C; Charney D N Engl J Med; 1997 Sep; 337(12):809-15. PubMed ID: 9295240 [TBL] [Abstract][Full Text] [Related]
16. Pharmacoeconomics of depot antipsychotics for treating chronic schizophrenia in Sweden. Einarson TR; Vicente C; Zilbershtein R; Piwko C; Bø CN; Pudas H; Jensen R; Hemels ME Nord J Psychiatry; 2014 Aug; 68(6):416-27. PubMed ID: 24274837 [TBL] [Abstract][Full Text] [Related]
17. Initiating clozapine treatment in the outpatient clinic: service utilization and cost trends. Luchins DJ; Hanrahan P; Shinderman M; Lagios L; Fichtner CG Psychiatr Serv; 1998 Aug; 49(8):1034-8. PubMed ID: 9712208 [TBL] [Abstract][Full Text] [Related]
18. Underprescribing of clozapine and unexplained variation in use across hospitals and regions in the Canadian province of Québec. Latimer E; Wynant W; Clark R; Malla A; Moodie E; Tamblyn R; Naidu A Clin Schizophr Relat Psychoses; 2013 Apr; 7(1):33-41. PubMed ID: 23367500 [TBL] [Abstract][Full Text] [Related]
19. Assessment of costs and benefits of drug therapy for treatment-resistant schizophrenia in the United Kingdom. Davies LM; Drummond MF Br J Psychiatry; 1993 Jan; 162():38-42. PubMed ID: 8425137 [TBL] [Abstract][Full Text] [Related]
20. Multiple outcome assessment in a study of the cost-effectiveness of clozapine in the treatment of refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia. Rosenheck R; Cramer J; Xu W; Grabowski J; Douyon R; Thomas J; Henderson W; Charney D Health Serv Res; 1998 Dec; 33(5 Pt 1):1237-61. PubMed ID: 9865219 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]